High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 1, 2000, Pages 322-330

  Bourcigaux, Nathalie ^a   Gaston, Véronique ^a   Logié, Armelle ^a   Bertagna, Xavier ^b   Le Bouc, Yves ^a   Gicquel, Christine ^a,c  

^a SERVICE DE DERMATOLOGIE   (France)

^b Institut Cochin   (France)

^c ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D2; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; PROTEIN P57; SOMATOMEDIN B;

ADOLESCENT; ADRENAL CORTEX TUMOR; ADULT; AGED; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CHROMOSOME 11P; CLINICAL ARTICLE; ENZYME ACTIVITY; FEMALE; GENE OVEREXPRESSION; HETEROZYGOSITY LOSS; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADRENAL CORTEX NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; AUTORADIOGRAPHY; BLOTTING, NORTHERN; BLOTTING, WESTERN; CDC2-CDC28 KINASES; CELL DIVISION; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P57; CYCLIN-DEPENDENT KINASES; CYCLINS; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PRECIPITIN TESTS; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; TUMOR CELLS, CULTURED;

EID: 0034455462     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.1.322     Document Type: Article

References (30)

1. Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors. Study on a series of 82 tumors
2. The role of the insulin-like growth factor system in human cancer
3. Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCI H295R cell line
4. Imprinting of a genomic domain of 11p15 and loss of imprinting in cancer: An introduction
5. p57 KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family is a candidate tumor suppressor gene
6. Cloning of p57 KIP2, a cyclin dependent kinase inhibitor with unique domain structure and tissue distribution
7. Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse
8. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15
9. Cancer cell cycles
10. Ribonucleic acid expression of the clustered imprinted genes, p57KIP2, insulin-like growth factor-II and H19 in adrenal tumors and cultured adrenal cells
11. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome
12. Genomic imprinting of human p57KIP2 and its reduced expression in Wilms' tumors
13. New p57KIP2 mutations in Beckwith-Wiedemann syndrome
14. Low frequency of p57KIP2 mutation in Beckwith-Wiedemann syndrome
15. Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms' tumors
16. Cyclin-dependant kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms' tumors
17. p57KIP2 is expressed in Wilms' tumor with LOH of 11p15.5
18. Reduced expression of the cyclin-dependent kinase inhibitor gene p57KIP2 in Wilms' tumor
19. Chromosome 11p15.5 regional imprinting: Comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors
20. Human p57KIP2 defines a new imprinted domain on chromosome lip but is not a tumour suppressor gene in Wilms' tumour
21. Clinical features of adrenocortical carcinoma, prognostic factors and the effect of mitotane therapy
22. NCI-H295 cell line: A pluripotent model for human adrenocortical studies
23. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
24. Rearrangements at 11p15 locus and overexpression of Insulin like growth factor-II gene in sporadic adrenocortical tumors
25. Cyclin dependent kinase regulation
26. A question of balance: The role of cyclin-kinase inhibitors in development and tumorigenesis
27. Inhibitors of mammalian G1 cyclin-dependent kinases
28. Expression of cell-cycle regulators p27KIP1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
29. Insulin-like growth factor I induces cyclin-D1 expression in MG63 human osteosarcoma cells in vitro
30. The role of the IGF I receptor in the regulation of cdc2 mRNA levels in fibroblasts